Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia) (CHO-CAP)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
G.A. de Wit, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00812084
First received: December 18, 2008
Last updated: December 18, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
No publications provided by UMC Utrecht

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):